Vanta Clinical Research Limited

Vanta Clinical Research Limited - pharma in Secunderabad, Telangana, India. FY 2026 financials & compliance.
CIN U73100TG2018PLC126673 Incorporated 12 September 2018 ROC Hyderabad HQ Secunderabad, Telangana, India
Active Public Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2021
₹1,983
▼ 100% YoY
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹3 Cr
Issued & subscribed
Open charges
₹30.01 Cr
Satisfied ₹17 Cr
Company age
8 yrs
Est. 2018
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
Brands
1
Associated brands

About Vanta Clinical Research Limited

Data last updated:

Vanta Clinical Research Limited is a public limited company based in Secunderabad, Telangana, India, a subsidiary of Vanta Bioscience Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 12 September 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2018PLC126673. Its GSTIN is 36AAGCV5789C1ZY (Telangana).

The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹3 Cr. It is led by directors including Dopesh Raja Mulakala and Shravan Chintapatla.

Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at No.02/G/308/G No.3/Ff/Sf/1 – 20 – 248 Umajay Complex Rasoolpura, Secunderabad, Telangana, India – 500003.

Its group structure includes 1 subsidiary.

The company is associated with 1 brand: Vanta Bioscience. As per MCA filings, the company has open charges of ₹30.01 Cr and satisfied charges of ₹17 Cr on record.

Vanta Clinical Research Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0005033). For more details, the company can be reached via its website vantabio.com.

Company details

CIN U73100TG2018PLC126673
Registration Number 126673
Incorporation Date 12 September 2018
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 November 2021
Date of Balance Sheet 31 March 2021
Parent Company Vanta Bioscience Limited
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0005033

Recognitions & Rankings of Vanta Clinical Research

MSME (Udyam registered) Ministry of MSME
Category
Micro (2022-23)
Udyam number
UDYAM-TS-02-0005033

Contact details

Vanta Clinical Research Limited's registered office is in Secunderabad, Telangana. Its website is vantabio.com. Its e-mail address is in the company report.

  • Email
  • Social Media
  • Registered Address
    No.02/G/308/G No.3/Ff/Sf/1 – 20 – 248 Umajay Complex Rasoolpura, Secunderabad, Telangana, India – 500003
  • Industry
    Pharma, Pharma Contract R&D

To see the full contact details of Vanta Clinical Research Limited, buy the company report.

Comprehensive company report
Vanta Clinical Research Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Vanta Clinical Research operates one associated brand: Vanta Bioscience. Each brand links to its own profile.

BrandDescriptionWebsite
GLP-certified preclinical contract research services are provided.vantabio.com

Financials of Vanta Clinical Research Limited

FY 2021 filings available

Vanta Clinical Research Limited reported revenue of ₹1,983 (down 100% YoY) for FY 2021.

Revenue · FY 2021
₹1,983 ▼ 100%

Financial Statement Summary

MetricsFY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹1,983
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Vanta Clinical Research Limited, buy the company report.

Board of directors of Vanta Clinical Research Limited

Vanta Clinical Research has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Dopesh Raja MulakalaDirector12 Sep 20188 Years 1 MonthsCurrent
Shravan ChintapatlaDirector18 Aug 20206 Years 2 MonthsCurrent
Mulakala Sajan KiranDirector07 Mar 20206 Years 7 MonthsCurrent

Peer comparison

Vanta Clinical Research Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Nano Formulations Private Limited₹6,800 (FY 2023)-74.0%Bhubaneswar, Odisha, India
Advanced Clinical Research Private Limited₹5,000 (FY 2025)Bengaluru, Karnataka, India
Vanta Clinical Research Limitedthis company₹1,983 (FY 2021)-100.0%Secunderabad, Telangana, India
Reametrix India Private Limited₹510 (FY 2019)Bangalore, Karnataka, India

To see the full peer comparison of Vanta Clinical Research Limited, buy the company report.

Auditor

Vanta Clinical Research Limited is audited by ITALIA & ASSOCIATES LLP for the financial year 2021.

Auditor firmFinancial yearFirm registration number
ITALIA & ASSOCIATES LLPFY 2021003793S

Shareholding

The shareholding of Vanta Clinical Research Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Vanta Clinical Research Limited, buy the company report.

Charges & borrowings

Open charges
₹30.01 Cr
Satisfied charges
₹17 Cr
Breakdown by lending institutions
Others₹19.97 Cr
State Bank of India₹10.04 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
28 Jun 2022100595387Others₹19.97 CrOpen
01 Jul 2020100353753State Bank of India₹10.04 CrOpen
03 Dec 2019100311512Axis Bank Limited₹17 CrSatisfied

To see the full charge records of Vanta Clinical Research Limited, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Vanta Clinical Research Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Group structure & subsidiaries

Vanta Clinical Research has 1 subsidiary company. This group structure data is as of FY 2021. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Vayam Research Solutions LimitedU73100TG2018PLC127550

To see the full group structure of Vanta Clinical Research Limited, buy the company report.

GST

Vanta Clinical Research has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AAGCV5789C1ZYTelanganaActive20 Jun 2019

To see the full GST registrations and return filing status of Vanta Clinical Research Limited, buy the company report.

Recent activity

Vanta Clinical Research Limited has 7 board changes on record since 2018: 5 appointments and 2 cessations. The latest: Venkata Rao Sadhanala ceased to be Director on 20 Nov 2020.

Charges
A charge with State Bank Of India of Rs. 10.04 Cr registered on 01 Jul 2020 with Charge ID 100353753 was modified on 25 Mar 2025.
Charges
A charge registered on 03 Dec 2019 via Charge ID 100311512 with Axis Bank Limited was fully satisfied on 26 Sep 2023.
Charges
A charge with Others amounted to Rs. 19.97 Cr with Charge ID 100595387 was registered on 28 Jun 2022.
AGM
Vanta Clinical Research Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.
Filing
Vanta Clinical Research Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Hyderabad.
Ceased
Venkata Rao Sadhanala ceased to be Director.
Appointed
Shravan Chintapatla was appointed as Director.
Charges
A charge with State Bank Of India amounted to Rs. 10.04 Cr with Charge ID 100353753 was registered on 01 Jul 2020.
Appointed
Mulakala Sajan Kiran was appointed as Director.
Ceased
Sailendrakumar Jagabandhu Goswami ceased to be Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 17.00 Cr with Charge ID 100311512 was registered on 03 Dec 2019.
Appointed
Dopesh Raja Mulakala was appointed as Director.

3 earlier events are in the company report.

Frequently asked questions

Vanta Clinical Research is an active public limited company based in Secunderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 12 September 2018 (8+ years old) and is registered under CIN U73100TG2018PLC126673.

Vanta Clinical Research has 3 current directors:

The latest financial statements of Vanta Clinical Research on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Vanta Clinical Research is 36AAGCV5789C1ZY, registered in Telangana.

The CIN (Corporate Identification Number) of Vanta Clinical Research is U73100TG2018PLC126673. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Vanta Clinical Research was incorporated on 12 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Vanta Clinical Research by revenue are Nano Formulations Private Limited, Advanced Clinical Research Private Limited, Reametrix India Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).

Venkata Rao Sadhanala ceased to be Director on 20 Nov 2020. Shravan Chintapatla was appointed as Director on 18 Aug 2020. Mulakala Sajan Kiran was appointed as Director on 07 Mar 2020. Vanta Clinical Research has 7 board changes on record in total.

Yes, Vanta Clinical Research is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0005033).

Vanta Clinical Research can be reached through the website vantabio.com. Its registered office is in Secunderabad, Telangana, India.

The registered office of Vanta Clinical Research is at No.02G308G No.3FfSf1 – 20 – 248 Umajay Complex Rasoolpura, Secunderabad, Telangana, India – 500003.